Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes.
Mamdouh N AkerWayne G BrisbaneLorna KwanSamantha GonzalezAlan M PriesterAdam KinnairdMerdie K DelfinEly FelkerAnthony E SiskDavid KuppermannLeonard S MarksPublished in: Cancer medicine (2023)
In the near to intermediate term, partial gland ablation with cryotherapy was found to be a safe and moderately effective treatment of intermediate-risk prostate cancer. Eradication of cancer was better determined by MRI-guided biopsy than by MRI or PSA.
Keyphrases
- prostate cancer
- radical prostatectomy
- contrast enhanced
- magnetic resonance imaging
- papillary thyroid
- diffusion weighted imaging
- radiofrequency ablation
- preterm infants
- computed tomography
- squamous cell
- rectal cancer
- helicobacter pylori infection
- gestational age
- ultrasound guided
- squamous cell carcinoma
- type diabetes
- skeletal muscle
- weight loss
- lymph node metastasis
- metabolic syndrome
- insulin resistance
- atrial fibrillation
- smoking cessation